1Hyman SE, Fenton WS. What are the right targets for psychopharmacology? Science, 2003 ; 299:350 - 351.
2Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophr Res. 2004 ; 72 : 21 - 28.
3Dickinson D, lannone VN, Wilk CM, et al. General and specific cognitive deficits in schizophrenia. Biol Psychiatry, 2004; 55 : 826 - 833.
4Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry, 2006; 67 : e12.
5Buchanan RW, Freedman R, Javitt DC, et al. Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Schizophr Bull. 2007.
6Green, MF, Nuechterlein KH. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res. 2004 ; 72 : 1 - 3.
7Geyer MA, Heinssen R. New approaches to measurement and treatment research to improve cognition in schizophrenia. Schizophr Bull. 2005; 31:806-809.
8Marder SR, Fenton W, Youens K. Schizophrenia, Ⅸ: Cognition in schizophrenia- the MATRICS initiative. Am J Psychiatry, 2004; 161: 25.
9Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1 : test selection, reliability, and validity. Am J Psychiatry, 2008; 165:203 - 213.
10Nuechterlein KH, Barch DM, Gold JM, et al. Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004 ; 72 : 29 - 39.
6ChoiJ,Medali A. Cognitive Rehabilitation in Schizophrenia[ J]. Psychiatry,2009,20(2) :25-31.
7Twamley EW, Jeste DV, Bellack AS. A review of cognitive training in schizophrenia [ J ]. Schizophr Bull, 2003,29 : 359-382.
8McGurk SR,Twamley EW,Sitzer DI,et al. A meta -analysis of cognitive remediation in schizophrenia [ J ]. Am J Psychiatry, 2007,164(12) :1791-1802.
9Wykes T, Reeder C, Comer J, et al. The effects of neurocognitive remediation on executive processing in patients with schizophrenia [ J ]. Schizophr Bull, 1999,25 : 291-307.
10Mueller DR, Roder V. Integrated Psychological Therapy for schizophrenia patients [ J ]. ExpertRev. Neurotherapeutics, 2007, 7(1):1 -3.
